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The aim of the study was to assess P300 event-related potentials (ERPs) in patients suffering 
from rheumatoid arthritis (RA) in relation to the duration of illness, degree of disease activity, 
anatomical and functional stage of the disease, pain intensity, and pain unpleasantness. The 
cross-sectional study included 53 women with RA (RA group; mean age 50.58 ± 0.93 years) 
and 27 healthy women (control group, C; 49.41 ± 1.08 years). The intensity and unpleasant-
ness of pain were determined using a visual analog scale (VAS); the functional status was as-
sessed using HAQ (Health Assessment Questionnaire), and the disease activity was estimated 
using the disease activity scale (DAS28). The P300 waves initiated by auditory stimulations 
according to the oddball paradigm were recorded from leads Fz and Cz. There were no sig-
nificant differences between the P300 latencies in both leads. At the same time, the average 
P300 amplitudes in both leads were found to be considerably lower (P < 0.05) in the RA 
group compared to the C group. Thus, there is a statistically significant amplitude difference 
between the P300 cognitive ERPs in RA patients and control subjects. 
Keywords: P300 event-related potentials (ERPs), rheumatoid arthritis, pain intensity, 
pain unpleasantness, visual analog scale (VAS).
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INTRODUCTION 
Rheumatoid arthritis (RA) is a chronic painful 
condition causing progressive irreversible damage 
to the articular and periarticular structures, their 
deformation and functional impairment, cognitive and 
emotional difficulties, and significant reduction of the 
quality of life [1]. Cognitive complaints, impairment 
of attention, memory (especially short-term) loss, loss 
of spatial orientation and concentration, visuospatial 
alterations, and disorders of motor planning and 
mental flexibility are frequently observed in patients 
with RA [2-5]. Data obtained from simple and 
complex psychometric measurements in patients 
suffering from RA are indicative of the impact of 
pain on cognitive functioning and demonstrate the 
necessity for developing new therapeutic strategies 
[6-8]. Application of modern methods of functional 
diagnostics demonstrated association of chronic pain 
with changes in the brain structures and functions in 
patients with RA [9, 10]. Literature data also suggest 
complex interaction of sensory processing, attention, 
and cognition with chronic painful conditions; further 
research on the mechanisms of pain perception and 
cognitive dysfunctions related to the mentioned 
pathology is needed [5, 11]. 
Studies on cognitive P300 potentials during of the 
last 20 years were rather intense and clearly indicated 
the importance of application in these phenomena in 
clinical studies. Cognitive event-related potentials 
(ERPs) are defined as small-amplitude phasic EEG 
potentials related to some cognitive events; such 
potentials represent a sensitive indicator of the state of 
higher cortical functions [12]. These potentials include 
a series of negative and positive waves with a wide 
distribution on the scalp; the respective components 
are marked N1, P1, N2, P2, and P3 (P300) waves. The 
P300 wave is an ERP usually registered within the so-
called oddball experimental paradigm. It is a positive 
wave whose peak latency in a healthy population 
varies between 300 and 500 msec after stimulation; a 
maximum amplitude of this potential is observed over 
the central and parietal regions of the cerebral cortex. 
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It is believed that the P300 wave is a neuroelectrical 
indicator of CNS activity related to processing of new 
information and guidance of attention to updating the 
memory performance [13, 14]. 
The P300 wave is a manifestation of the CNS in-
volvement in the processing of new information when 
attention is engaged in refreshing memory. It is an en-
dogenous response to a task that is not a certain direct 
answer to that of the target stimulus [15]. The ampli-
tude of this potential is associated with the scope of at-
tention focusing on a task and with the refreshing rate 
of the contents of working memory. Variations in the 
amplitude of P300 reflect the level and quality of han-
dling incoming information. The P300 latency is a mea-
sure of the relative duration of the evaluation process, 
i.e., a parameter that represents the neurophysiologi-
cal correlate with the rate of the cognitive processes 
[15]. Components of P300 ERPs are susceptible to the 
effects of many factors (nature of the stimuli and a va-
riety of biological determinants), but this does not di- 
minish the significance and clinical application of these 
potentials [14, 16, 17]. The P300 ERPs were tested 
many times in a number of clinical conditions [18]. 
The aim of our study was to examine the parameters 
of auditory P300 potentials in RA patients in relation 
to the duration of illness, degree of disease activity, 
anatomical and functional stage of the disease, and in-
tensity and unpleasantness of pain.  
METHODS 
The study involved 80 subjects who were familiar 
with the preliminary examination. The RA group 
included 53 women (mean age 50.58 ± 0.93 years) 
who fulfilled the criteria for the diagnosis of RA based 
on the American Rheumatology Association (ARA, 
1987) statements. The C (control) group consisted of 
27 healthy women (age 49.41 ± 1.08 years) and was 
used to define the norms of neuropsychological and 
neurophysiological parameters taken into account in 
the tests. Each participant was provided with detailed 
information on how to prepare for the test and the type 
of applied tests and tasks. 
The exclusion criteria included hearing impairment, 
dementia, neurological and psychiatric diseases, 
head trauma, use of psychoactive substances and/or 
antidepressants three weeks before the survey, and 
surgery a month before the survey.
In the RA group, the following parameters were 
collected: number of painful and swollen joints, 
intensity of pain in the joints of patients evaluated by 
a visual analog scale (VAS) of 0-100 mm, degree of 
discomfort according to the VAS of 0-100 mm, speed 
sedimentation rate, a disease activity index, anatomical 
stage, and functional class of patients.
Auditory P300 ERPs. Registration of auditory 
P300 ERPs was performed using a Medtronic set. Two 
AgCl electrodes (impendance below 5 kΩ) were fixed 
in the Fz and Cz positions according to the standard 
10-20 international system. The reference electrode 
was composed of two linked contacts on the mastoids, 
and the grounding electrode was on the subject’s 
forearm. We used the oddball paradigm with two tones, 
“standard” of 90 dB and 1 kHz and “unexpected” of 
90 dB and 2 kHz, presented binaurally with randomized 
irregular intervals through special headsets. Subjects 
were instructed to ignore the standard tones and to 
react as quickly as possible to the unexpected tone by 
counting and pressing a lever set held in the dominant 
hand. Two hundred sixty trials with the relationship 
between the standard and unexpected tones of 80 vs. 
20% were recorded. 
Processing of ERP waves included individual visual 
identification of the highest positive wave within a 
220-450 msec window for each lead and measurements 
of the amplitude and latency of P300 potentials.
Statistical Analysis. Parametric (Student’s t-test) 
and nonparametric (Mann–Whitney test and χ2 test) 
tests were used to compare the distributions related 
to two groups. To compare three or more groups of 
respondents, the analysis of variance (ANOVA) 
and Kruskal–Wallis test were used. Correlation of 
continuous variables was examined by calculation of 
the Pearson correlation coefficients. 
The software package STATISTICA 8.0 licensed 
from the University of Novi Sad was used. 
RESULTS 
The RA and C groups did not differ significantly 
from each other in relation to age, education level, or 
marital status (P > 0.1 in all cases). 
The results of tests of functional ability of the 
patients (RA group) using the Health Assessment 
Questionnaire (HAQ) showed the average value of 
0.92 ± 0.67, and the average disease activity (DAS28) 
was 4.99 ± 0.85 (Table 1). Thirty one (58.49%) patients 
had moderately active disease, while 22 (41.51%) had 
highly active disease.
A rather high average value of the pain intensity 
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according to the VAS scale (56.51 mm) and the 
average pain unpleasantness of 58.11 mm were found 
(Table 1). Twenty eight (52.83%) RA patients had a 
pain intensity on the VAS scale greater than 50 mm, 
and 31 subjects (58.5%) manifested a strong degree of 
pain unpleasantness (VAS ˃ 50 mm) (Table 2).
Auditory P300 ERPs. The mean latencies of the 
P300 wave in leads Fz and Cz were 332.53 ± 21.63 
and 331.38 ± 23.69 msec in the C group, while the 
respective values in the RA group were 334.74 ± 36.54 
and 339.07 ± 36.02 msec. There were no significant 
intergroup differences between the P300 latencies 
recorded from both Fz and Cz (P > 0.1 in both cases). 
The mean amplitudes of the examined ERP in leads Fz 
and Cz were 10.84 ± 8.01 and 9.12 ± 6.72 µV in the 
C group vs. 6.09 ± 4.56 and 5.41 ± 3.27 µV in the RA 
group, respectively. Thus, the amplitudes of auditory 
P300 potentials recorded within the oldball paradigm 
were significantly smaller in patients suffering from 
RA, as compared with the analogous values in healthy 
subjects. 
Estimation of the correlation coefficients for 
the parameters of P300 potentials with the indices 
of disease activity showed statistically significant 
inverse correlations of the P300 latency in leads Fz 
and Cz with the functional class and intensity of 
T a b l e 1. Values of the Estimates of Disease Activity in the RA Group
Т а б л и ц я 1. Значення оцінок активності хвороби у пацієнтів із ревматоїдним артритом
Indices of disease activity M ± s.d. 
Disease duration, years 9.83 ± 7.74
Anatomical stage 2.00 ± 0.64
Functional class 2.06 ± 0,61
Disease acitivity (DAS28) 4.99 ± 0.85
HAQ 0.92 ± 0.67
Intensity of pain, VAS, mm 56.51 ± 21.92
Unpleasantness of pain, VAS, mm 58.11 ± 23.57
Footnotes: means ± s.d. are shown, DAS28 is the disease activity score 28, HAQ is the Health Assessment Questionnaire, and VAS in the 
visual analog scale
T a b l e 2. Intensity and Unpleasantness of Pain in the RA Group Estimated by VAS
Т а б л и ц я 2. Інтенсивність та неприємність болю, оцінювані згідно з VAS
VAS, mm
Intensity of pain Unpleasantness of pain
n % n %
< 25 5 9.43 7 13.21
25 to 50 20 37.74 15 28.30
51 to 75 18 33.96 14 26.42
> 75 10 18.87 17 32.08
Total 53 100 53 100
T a b l e 3. Correlation of the P300 ERP Parameters with Indices of Disease Activity in the RA Group
Т а б л и ц я 3. Кореляції параметрів хвилі P300 з індексами активності хвороби у пацієнтів із ревматоїдним артритом 
Indices of disease activity
P values for the P300
amplitude in Fz latency in Fz amplitude in Cz latency in Cz
Duration of illness –0.17 –0.01 –0.15 –0.03
Anatomical stage –0.05 –0.22 –0.15 –0.21
Functional class –0.12 –0.32 –0.12 –0.30
DAS28 –0.12 –0.12 0.01 –0.15
HAQ –0.18 –0.10 –0.06 –0.09
Intensity of pain –0.21 –0.38 –0.23 –0.40
Unpleasantness of pain –0.22 –0.20 –0.16 –0.20
Footnote: P values greater than 0.3 are shown in bold.
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pain by the VAS (P < 0.05; Table 3). In the group of 
RA patients, there was weak correlation of the P300 
latency in the above leads with unpleasantness of pain 
(P = 0.065) and some trend toward correlation with 
the anatomical stage of RA (P < 0.1; Table 3). In this 
table, the coefficients of correlation between the P300 
amplitudes in Fz and Cz and indices of disease activity 
are also shown. 
DISCUSSION 
Complex cognitive functions are particularly 
vulnerable with respect to the impact of various factors, 
and their dysfunction and recovery can be monitored 
by applying the method of ERP recording. Auditory 
P300 ERPs are often applied for the assessment 
of cognitive functions; they have sufficiently high 
amplitudes and long enough latency. These potentials 
can be registered under relatively simple experimental 
conditions and are reliable and reproducible [17]. The 
P300 latency is an indicator of the potential rate of 
stimulus classification, while the amplitude reflects 
brain activity associated with the task. It is believed 
that comparatively longer latencies of the P300 wave 
show that the stimulus evaluation time is prolonged, 
while lower amplitudes are related to the reduced 
capacity of attention that is characteristic of the 
painful condition [18, 19].
Yoldas and al. [20] compared the cognitive function 
in 11 patients with chronic pain and in healthy subjects 
and found significantly lower P300 amplitudes, but not 
longer latencies, compared to those in healthy subjects. 
These authors showed that there is a correlation 
between the amplitude of P300 potentials and pain 
intensity (myalgic total score).
Comparable results were obtained by Alagonlu et 
al. [22], who believed that a decline in the amplitude 
of the P300 potential is indicative of a noticeable 
cognitive dysfunction in subjects with chronic pain. 
Results of the analysis of the effects of pain on 
the P300 ERP components are contradictory to some 
extent. In some studies, pain-related differences in 
the P300 latency were not detected [21-23], while 
Alagonlu et al. [20] found an increase in the latency 
in patients suffering from chronic pain (fibromyalgia 
syndrome), compared to that in healthy subjects. We 
found neither a significant increment nor a noticeable 
trend toward such a change in the average P300 
latency in RA patients. At the same time, there was 
a clear statistically significant difference between the 
amplitudes of P300 waves in Fz and Cz sites in the RA 
and C groups; the respective values in the RA group 
were noticeably smaller than those in healthy subjects 
(Fig. 1). This is consistent with the findings of other 
authors [13, 17, 22, 23]. 
The obtained results of the measurement of 
characteristics of P300 ERPs in patients with RA 
should be interpreted considering a number of 
negative impacts on the cognitive functions under 
condition of this pathology. The action of these 
factors can be partly corrected by kinesiotherapy 
(improved cerebral circulation, increased “arousal,” 
more effective consumption of oxygen, changes in the 
concentration of endorphins). A wide range of research 
on the relationship between psychological distress-
depression/chronic pain and cognitive abilities in 
patients with RA did not give clear information in this 
respect [24-28]. Application of functional magnetic 
resonance imaging showed that the association of pain 
with fear and anxiety activates various brain structures, 
leading to the development of cognitive dysfunction 
[29-31]. The most intense correlation between pain 
and ERP P300 characteristics are manifested when 
recording of the latter is related to easy cognitive tasks 
[32]. 
Examination of the correlation between parameters 
of the P300 potentials and indices of disease activity 
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F i g. 1. Average amplitudes (µV) of the P300 
wave in leads Fz (A) and Cz (B) in the control 
(C) and rheumatoid arthritis (RA) groups.
Середні амплітуди потенціалів P300 у 
відведеннях Fz (A) та Cz (B) у групах 
контролю (C) та пацієнтів із ревматоїдним 
артритом (RA).
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in the RA group allowed us to find a statistically 
significant inverse correlation between the P300 
latencies with the intensity of pain by VAS (P < 0.05) 
and functional class (P < 0.05), which is consistent 
with results of the studies conducted in patients with 
various chronic pain conditions [22]. 
In the group of RA patients, we also found a 
negative weak correlation between the latencies of 
P300 potentials and pain unpleasantness estimated 
according to VAS (P < 0.1). 
The studies carried out have not provided researchers 
with clear answers on how the cognitive mechanisms 
are impaired under chronic pain conditions. Therefore, 
further research on predictive factors with respect to 
cognitive dysfunction is necessary, and analysis of 
ERP characteristics in the respective groups may be 
valuable. 
All testing procedures were in accordance with the 
ethical standards of the responsible Committees on human 
experimentation (institutional and national) and with the 
Helsinki Declaration of 1975, as revised in 2000. Written 
informed consent was obtained from all persons included in 
the study.
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Р е з ю м е
Були досліджені параметри пов’язаних із  подією 
потенціалів (ППП) P300 у пацієнтів, що страждають на 
ревматоїдний артрит (РА), та зв’язок цих параметрів із 
тривалістю та інтенсивністю захворювання, анатомічною 
та функціональною стадіями останнього, інтенсивністю та 
неприємністю відчуттів болю. У порівняльне дослідження 
були залучені 53 жінки з РА (група RA, середній вік 50.58 ± 
± 0.94 року) та 27 здорових жінок (контрольна група C, 
49.41 ± 1.08 року). Інтенсивність та рівень неприємності 
болю визначали за допомогою візуальної аналогової шка-
ли (VAS), функціональний статус – згідно з  опитуваль-
ником HAQ, а інтенсивність хвороби – за шкалою DAS28. 
Потенціали P300 ініціювали акустичною стимуляцією 
відповідно до oddball-парадигми та відводили від точок 
Fz та Cz. Усереднені значення латентних періодів хвилі 
P300 в групах RA та C не демонстрували якихось істотних 
відмінностей. У той же час усереднені амплітуди P300 в 
обох кортикальних зонах у групі RA були вірогідно нижчи-
ми (P < 0.05), ніж відповідні величини в групі C. Таким чи-
ном, існує статистично значуща різниця між характеристи-
ками когнітивного ППП P300 у пацієнтів із ревматоїдним 
артритом та здорових суб’єктів, що вказує на негативні 
зміни сенсорного процесінга та уваги, а також когнітивні 
дисфункції, виниклі під впливом хронічного болю. 
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